Walleye Trading LLC Allakos Inc. Transaction History

Walleye Trading LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$5.66 - $8.42 $67,772 - $100,821	11,974 New	11,974 $100,000
Q2 2022 Aug 08, 2022	SELL	$2.6 - $6.14 $109,878 - $259,482	-42,261 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$5.08 - $9.81 $16,449 - $31,764	-3,238 Reduced 7.12%	42,261 $241,000
Q4 2021 Feb 14, 2022	BUY	$8.55 - $111.89 $389,016 - $5.09 Million	45,499 New	45,499 $445,000

64.7M

47.1K

Ticker ALLK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,726,096
Market Cap $82.2M
Description
Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and...

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Trading LLC with notifications on news.